AKI - the other main type of kidney disease - can be caused by dehydration, blood loss, urinary tract obstructions such as ...

• Fenoldopam (a medicine that rapidly widens and relaxes blood vessels) probably reduces the risk of developing acute kidney injury (AKI) (a condition where the kidneys suddenly lose their ability to ...

图说：近日，上海交通大学医学院分子医学研究院杨朝勇团队与附属仁济医院泌尿科郑军华团队在《Nature Communications》上合作发表研究论文 ...

The following is a summary of “Impact of AKI on metabolic compensation for respiratory acidosis in ICU patients with AECOPD,” ...

Background: Patients on anti-tuberculosis treatment may develop acute kidney injury (AKI), but little is known about the renal outcome and prognostic factors, especially in an aging population.

REVB READ THE FULL REVB RESEARCH REPORT Revelation Biosciences (NASDAQ:REVB) announced that the FDA has accepted the company’s IND application for Gemini. This announcement allows the Company to ...

Drug-induced AKI (acute kidney injury) is common and may include medications not previously known to exhibit this safety signal.

Revelation Biosciences, Inc. (NASDAQ: REVB) (the "Company" or "Revelation"), a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the treatment of ...

A study was conducted to determine the prognostic impact of neutrophil-to-lymphocyte ratio in patients receiving PCI who do and do not have diabetes.

Reports of GLP-1RA–associated acute kidney injury (AKI) have emerged, but the risk of GLP-1RA–associated AKI among patients on anti-cancer drugs is unclear. Surprisingly, new research suggests that ...

Discover how machine learning predicts successful discontinuation of renal replacement therapy in critically ill patients ...